Concord Drugs
CONCORDBSE

Concord Drugs

₹82.68-1.56 (1.85%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
82.65
Today’s high
87.50
52 week low
29.00
52 week high
92.52
Open price
87.50
Previous close
84.24
Live volume
490
Lower circuit
75.82
Upper circuit
92.66

Fundamentals

Market Cap
₹111Cr
ROE
1.67%
P/E Ratio(TTM)
195.91
EPS(TTM)
0.43
P/B Ratio
2.42
Dividend Yield
0.00%
Industry P/E
33.38
Book Value
34.87
Debt to Equity
0.50
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
DEC '25
Revenue (Cr)
₹16.99
+65.27%
Profit (Cr)
₹0.22
+15.79%
02.25920.2536
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Revenue growthValue
1Y (TTM)+57%
3Y CAGR-8%
Profit growthValue
1Y (TTM)-4%
3Y CAGR-40%

About

Concord Drugs Limited is an Indian pharmaceutical company where the management is committed to achieving excellence through comprehensive quality management in all its operations. The company's strategic focus is on creating innovative drug delivery systems, including technologies like Sustained Release and Modified Release pellets, using the latest processes. It runs a state-of-the-art cGMP contract manufacturing facility, offering a full range of services for pharmaceutical development and drug product manufacturing. The company has also established robust internal financial controls to ensure the safety of its assets and the reliability of its financial transactions. Its main strength lies in delivering complete end-to-end solutions to customers and partners with its Ready-to-Fill Pellets and Finished Pharmaceutical Formulations. This positions Concord among a select few Indian pharmaceutical companies with a cutting-edge WHO-GMP certified facility, enabling the production of superior quality products.;
CEO/MD
Mr. S. Nagi Reddy
Founded in
1995
BSE symbol
538965

Shareholding Pattern

Jun '25
Sep '25
Nov '25
Dec '25
Mar '26
Promoters
54.39%
Retail And Others
45.61%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹860.60
+16.20 (1.92%)
L
    H
    4,840.6636.564.74
    ₹368.05
    -4.25 (1.14%)
    L
      H
      4,063.8684.9515.37
      ₹403.60
      -2.55 (0.63%)
      L
        H
        3,796.1942.365.2
        Aarti DrugsAARTIDRUGS
        ₹389.30
        -6.55 (1.65%)
        L
          H
          3,604.2517.82.45
          2026
          14
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          8
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks